GH1 and hypopituitarism: As the adjuvant treatment for GH-secreting PitNETs, FSRT and SRS are preferable to EBRT because earlier biochemical remission is achieved [64, 65] and lower rates of hypopituitarism [62] and post-treatment visual changes [63] are reported.